US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
ATE152626T1
(de)
*
|
1989-03-24 |
1997-05-15 |
Univ California |
Endothelialer zellwachsfaktor, isolierung und expression
|
US6899882B1
(en)
|
1989-03-24 |
2005-05-31 |
The Regents Of The University Of California |
Endothelial cell growth factor methods of isolation and expression
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US20030114374A1
(en)
*
|
1989-05-12 |
2003-06-19 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US7300791B2
(en)
*
|
1989-05-12 |
2007-11-27 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
CA2017379C
(en)
*
|
1989-05-24 |
2002-06-25 |
Kenneth A. Thomas, Jr. |
Purification and characterization of a glioma-derived growth factor
|
US5726152A
(en)
*
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
DE69229454T2
(de)
*
|
1991-03-28 |
2000-01-05 |
Merck & Co., Inc. |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
US5514779A
(en)
*
|
1991-06-07 |
1996-05-07 |
Zeneca Limited |
Biocidal proteins from plants
|
AU2861692A
(en)
*
|
1991-10-18 |
1993-05-21 |
Beth Israel Hospital Association, The |
Vascular permeability factor targeted compounds
|
EP0612348B1
(de)
*
|
1991-11-04 |
2003-04-23 |
Genetics Institute, LLC |
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
PT101031B
(pt)
*
|
1991-11-05 |
2002-07-31 |
Transkaryotic Therapies Inc |
Processo para o fornecimento de proteinas por terapia genetica
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
PT662146E
(pt)
*
|
1992-09-03 |
2000-12-29 |
Univ California |
Factor que afecta o tecido dorsal e composicoes
|
HU225646B1
(en)
*
|
1992-10-28 |
2007-05-29 |
Genentech Inc |
Hvegf receptors as vascular endothelial cell growth factor antagonists
|
WO1994025056A2
(en)
*
|
1993-04-29 |
1994-11-10 |
Washington University |
Use of platelet-derived growth factor to improve collateral circulation
|
EP0706563B1
(de)
*
|
1993-06-29 |
2004-10-06 |
Chiron Corporation |
Verkürzter keratinocyten-wachstumsfaktor(kgf)mit erhöhter biologischer aktivität
|
WO1995006131A1
(en)
*
|
1993-08-23 |
1995-03-02 |
Monash University |
A method for the assay, prophylaxis and/or treatment of human disease conditions
|
US5464815A
(en)
*
|
1993-09-08 |
1995-11-07 |
Genentech, Inc. |
Inhibition of heparin-binding
|
CA2179638A1
(en)
*
|
1993-12-24 |
1995-07-06 |
Peter Schulz-Knappe |
Human circulating cytokine cc-1
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
US5861499A
(en)
*
|
1994-02-10 |
1999-01-19 |
Imclone Systems Incorporated |
Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
|
US5840301A
(en)
*
|
1994-02-10 |
1998-11-24 |
Imclone Systems Incorporated |
Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US7109308B1
(en)
*
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
ATE309360T1
(de)
*
|
1994-03-08 |
2005-11-15 |
Human Genome Sciences Inc |
Vaskularer endothelialer wachstumsfaktor 2
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US6608182B1
(en)
*
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US6150092A
(en)
*
|
1994-06-27 |
2000-11-21 |
Taogosei Company, Ltd. |
Antisense nucleic acid compound targeted to VEGF
|
US6152141A
(en)
*
|
1994-07-28 |
2000-11-28 |
Heartport, Inc. |
Method for delivery of therapeutic agents to the heart
|
WO1996006641A1
(en)
*
|
1994-08-29 |
1996-03-07 |
Prizm Pharmaceuticals, Inc. |
Conjugates of vascular endothelial growth factor with targeted agents
|
US6451523B1
(en)
*
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
IL114615A0
(en)
*
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
JP3911017B2
(ja)
*
|
1995-02-09 |
2007-05-09 |
アメリカ合衆国 |
腫瘍遺伝子Int6のヌクレオチド配列及び推定アミノ酸配列
|
US7232667B2
(en)
*
|
1995-02-14 |
2007-06-19 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 polynucleotides
|
US6077692A
(en)
*
|
1995-02-14 |
2000-06-20 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US6693077B1
(en)
|
1995-02-14 |
2004-02-17 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
CN1194090C
(zh)
*
|
1995-03-02 |
2005-03-23 |
阿穆拉德业务有限公司 |
一种新的生长因子和编码这种生长因子的基因序列
|
US7160991B1
(en)
*
|
1995-03-02 |
2007-01-09 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor polypeptides
|
AU2236895A
(en)
*
|
1995-03-30 |
1996-10-16 |
Human Genome Sciences, Inc. |
Human g-protein coupled receptors
|
IL117645A
(en)
*
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
US7427492B1
(en)
*
|
1995-06-05 |
2008-09-23 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human tumor necrosis factor receptor-like2
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
US20020150578A1
(en)
*
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
US20020026037A1
(en)
*
|
1995-06-06 |
2002-02-28 |
Jing-Shan Hu |
Vascular endothelial growth factor 3 antibodies
|
US6013483A
(en)
*
|
1995-06-07 |
2000-01-11 |
Human Genome Sciences, Inc. |
DNA encoding endothelial monocyte activating polypeptide III
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
ATE228004T1
(de)
*
|
1995-08-15 |
2002-12-15 |
Connetics Corp |
Verwendung von relaxin zur stimulierung der angiogenese
|
US6451764B1
(en)
|
1995-09-08 |
2002-09-17 |
Genentech, Inc. |
VEGF-related protein
|
WO1997012972A2
(en)
*
|
1995-09-29 |
1997-04-10 |
Universita'degli Studi Di Siena |
Regulated genes and uses thereof
|
US6329169B1
(en)
*
|
1995-09-29 |
2001-12-11 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding cytostatin II
|
ES2206602T3
(es)
*
|
1995-10-23 |
2004-05-16 |
The Children's Medical Center Corporation |
Compuestos y metodos terapeuticos inhibidores de angiogenesis.
|
US7393943B1
(en)
*
|
1995-12-08 |
2008-07-01 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a human chemotactic cytokine I
|
US7888466B2
(en)
*
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US7084252B1
(en)
*
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7063958B1
(en)
*
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
WO1997026277A2
(en)
*
|
1996-01-22 |
1997-07-24 |
Creative Biomolecules, Inc. |
Morphogen analogs and methods for producing them
|
US20030185792A1
(en)
*
|
1996-01-22 |
2003-10-02 |
Curis, Inc. |
Morphogen analogs of bone morphogenic proteins
|
CA2246332C
(en)
|
1996-02-15 |
2009-04-14 |
Biosense, Inc. |
Catheter based surgery
|
US6713061B1
(en)
*
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
*
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6410268B1
(en)
|
1996-03-18 |
2002-06-25 |
Human Genome Sciences, Inc. |
Polynucleotides encoding chemokine alpha-3
|
US6443974B1
(en)
*
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
US20030129643A1
(en)
*
|
1996-08-23 |
2003-07-10 |
Human Genome Sciences, Inc. |
T1 receptor-like ligand I
|
EP0956339B1
(de)
*
|
1996-08-23 |
2005-10-12 |
Ludwig Institute For Cancer Research |
Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d)
|
US6541217B2
(en)
*
|
1996-08-27 |
2003-04-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Hematopoietic stem cell growth factor (SCGF)
|
US6013780A
(en)
*
|
1996-09-06 |
2000-01-11 |
Technion Research & Development Co. Ltd. |
VEGF145 expression vectors
|
ES2274549T3
(es)
*
|
1996-09-24 |
2007-05-16 |
MERCK & CO., INC. |
Compuestos para la inhibicion de la angiogenesis por terapia de genes .
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US6743422B1
(en)
|
1996-10-15 |
2004-06-01 |
Amgen, Inc. |
Keratinocyte growth factor-2 products
|
US20030144202A1
(en)
*
|
1996-10-15 |
2003-07-31 |
Amgen Inc. |
Uses of keratinocyte growth factor-2
|
US6998418B1
(en)
|
1996-11-05 |
2006-02-14 |
Gp Medical, Inc. |
Acellular biological material chemically treated with genipin
|
US20060171907A1
(en)
*
|
1996-11-21 |
2006-08-03 |
The Procter & Gamble Company |
Oral care compositions providing enhanced whitening and stain prevention
|
JP4138013B2
(ja)
*
|
1996-12-23 |
2008-08-20 |
イミュネックス・コーポレーション |
Tnfスーパーファミリーのメンバーであるnf−kappa bの受容体アクティベーターに対するリガンド
|
BR9806954A
(pt)
*
|
1997-01-14 |
2000-03-21 |
Human Genome Sciences Inc |
Receptores 6a e 6b do fator de necrose tumoral
|
US20040013664A1
(en)
*
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
US7285267B2
(en)
*
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
US20030165467A1
(en)
*
|
1997-01-21 |
2003-09-04 |
Technion Research & Development Co., Ltd. |
Angiogenic factor and use thereof in treating cardiovascular disease
|
EP0972022A2
(de)
*
|
1997-01-21 |
2000-01-19 |
Human Genome Sciences, Inc. |
Für rezeptoren kodierende polynukleotide und polypeptide
|
US20020155538A1
(en)
*
|
1997-01-23 |
2002-10-24 |
Incyte Pharmaceuticals, Inc. |
Novel endothelial growth factor
|
WO1998033918A1
(en)
*
|
1997-02-05 |
1998-08-06 |
The Regents Of The University Of California |
Morphogenic proteins
|
EP0973888A1
(de)
*
|
1997-02-06 |
2000-01-26 |
Human Genome Sciences, Inc. |
Von dendritischen zellen abgeleiteten wachstumsfaktor
|
US6485942B1
(en)
|
1997-02-14 |
2002-11-26 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
|
US6395707B1
(en)
|
1997-02-14 |
2002-05-28 |
Genentech, Inc. |
Methods of treatment utilizing variants of vascular endothelial cell growth factor
|
US20060084082A1
(en)
|
1997-03-07 |
2006-04-20 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
WO1999035158A1
(en)
*
|
1998-01-07 |
1999-07-15 |
Human Genome Sciences, Inc. |
36 human secreted proteins
|
WO2000029422A1
(en)
*
|
1998-11-12 |
2000-05-25 |
Human Genome Sciences, Inc. |
31 human secreted proteins
|
WO2000075375A1
(en)
*
|
1999-06-07 |
2000-12-14 |
Human Genome Sciences, Inc. |
26 human secreted proteins
|
US7196164B2
(en)
*
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
EP1017421B1
(de)
|
1997-03-07 |
2005-05-25 |
The Wistar Institute Of Anatomy And Biology |
Verwendung von Adenoviralen Vektoren, die PDGF oder VEGF exprimieren, ZUR HEILUNG VON GEWEBSDEFEKTEN UND ZUR INDUZIERUNG DER HYPERVASKULITÄT IN SÄUGERGEWEBEN
|
US6951924B2
(en)
*
|
1997-03-14 |
2005-10-04 |
Human Genome Sciences, Inc. |
Antibodies against secreted protein HTEBYII
|
US7968689B2
(en)
*
|
1997-03-07 |
2011-06-28 |
Human Genome Sciences, Inc. |
Antibodies to HSDEK49 polypeptides
|
US6541212B2
(en)
*
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US5935813A
(en)
*
|
1997-03-20 |
1999-08-10 |
Incyte Pharmaceuticals, Inc. |
Human pancreatitis-associated protein
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1005355A4
(de)
*
|
1997-04-15 |
2002-07-17 |
Radix Organization Inc |
Verfahren zur behandlung von magendarmgeschwüren und die dazugehörigen mittel
|
US7205381B2
(en)
*
|
1997-04-21 |
2007-04-17 |
Schering Corporation |
Mammalian cytokines; related reagents and methods
|
US7220557B2
(en)
|
1997-04-24 |
2007-05-22 |
Human Genome Sciences, Inc. |
METH1 polynucleotides
|
US20030166065A1
(en)
*
|
1997-04-24 |
2003-09-04 |
Human Genome Sciences, Inc. |
Novel integrin ligand ITGL-TSP
|
AU741330B2
(en)
*
|
1997-04-30 |
2001-11-29 |
F. Hoffmann-La Roche Ag |
Rat ST38.2 chemokine
|
US6342369B1
(en)
*
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6506569B1
(en)
*
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
US6031155A
(en)
*
|
1997-06-05 |
2000-02-29 |
Cameron-Mills; Verena |
Arabinoxylan degradation
|
US20060223077A1
(en)
*
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
US5891674A
(en)
*
|
1997-06-19 |
1999-04-06 |
Incyte Pharmaceuticals, Inc. |
Insulin receptor tyrosine kinase substrate
|
EP0996725A1
(de)
*
|
1997-06-27 |
2000-05-03 |
Human Genome Sciences, Inc. |
Menschliches nk-3 verwandtes prostata-spezifiches gen -1
|
AU8586198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor, lefty-1
|
WO1999006443A1
(en)
*
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor, lefty-2
|
WO1999006445A1
(en)
*
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-15
|
WO1999025825A2
(en)
*
|
1997-11-13 |
1999-05-27 |
Genset |
EXTENDED cDNAs FOR SECRETED PROTEINS
|
US6416973B1
(en)
*
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
US20020112251A1
(en)
*
|
1997-08-04 |
2002-08-15 |
Mccarthy Sean A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
FR2767135B1
(fr)
*
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
US6699672B1
(en)
*
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US20030161823A1
(en)
*
|
1998-08-31 |
2003-08-28 |
Neta Ilan |
Therapeutic and cosmetic uses of heparanases
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
DE69841140D1
(de)
*
|
1997-09-17 |
2009-10-22 |
Human Genome Sciences Inc |
Interleukin-17 rezeptor-ähnliches protein
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
US6482923B1
(en)
*
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
US20030054400A1
(en)
*
|
1997-09-17 |
2003-03-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP3956272B2
(ja)
*
|
1997-09-22 |
2007-08-08 |
敏男 宮田 |
メグシンタンパク質
|
US7321023B2
(en)
*
|
1997-11-07 |
2008-01-22 |
Incyte Corporation |
SP16 protein
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
US6808890B2
(en)
*
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
US20060286639A1
(en)
*
|
1997-11-13 |
2006-12-21 |
Serono Genetics Institute S.A. |
Complementary DNAs encoding proteins with signal peptides
|
US20060009633A9
(en)
*
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
WO1999027096A1
(en)
|
1997-11-22 |
1999-06-03 |
Hyseq, Inc. |
A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
|
US20020132981A1
(en)
*
|
1997-12-03 |
2002-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1999029854A1
(en)
*
|
1997-12-08 |
1999-06-17 |
Ontogeny, Inc. |
Human patched genes and proteins, and uses related thereto
|
US6303770B1
(en)
*
|
1997-12-10 |
2001-10-16 |
Zymogenetics, Inc. |
Nucleic acids encoding mammalian alpha helical protein-1
|
US6869927B1
(en)
|
1997-12-22 |
2005-03-22 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
NZ505324A
(en)
|
1997-12-22 |
2002-11-26 |
Human Genome Sciences Inc |
Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
|
US6703485B2
(en)
*
|
1997-12-23 |
2004-03-09 |
The Trustees Of Columbia University In The City Of New York |
Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
|
KR100628697B1
(ko)
*
|
1997-12-24 |
2006-09-28 |
루드빅 인스티튜트 포 캔서 리서치 |
맥관 내피 성장인자 d를 발현하는 발현 벡터와 셀라인,및 흑색종을 치료하는 방법
|
JPH11187884A
(ja)
*
|
1997-12-26 |
1999-07-13 |
Hsp Kenkyusho:Kk |
熱ショック転写因子結合蛋白質
|
US6297367B1
(en)
*
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
US20030170213A1
(en)
*
|
1998-01-23 |
2003-09-11 |
Marc F. Charette |
Methods and compositions for enhancing cognitive function using morphogenic proteins
|
US7722671B1
(en)
|
1998-01-27 |
2010-05-25 |
St. Jude Medical, Inc. |
Medical devices with associated growth factors
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
US6309370B1
(en)
|
1998-02-05 |
2001-10-30 |
Biosense, Inc. |
Intracardiac drug delivery
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
EP1053326A2
(de)
|
1998-02-06 |
2000-11-22 |
Collateral Therapeutics |
Varianten des angiogenen faktors vaskularer endothelialzell-wachstumsfaktor: vegf
|
US6706869B1
(en)
*
|
1998-02-11 |
2004-03-16 |
Wyeth |
Map kinase phosphatases and polynucleotides encoding them
|
US6395890B1
(en)
*
|
1998-02-20 |
2002-05-28 |
Zymogenetics, Inc. |
Nucleic acids encoding connective tissue growth factor homologs
|
US6054276A
(en)
|
1998-02-23 |
2000-04-25 |
Macevicz; Stephen C. |
DNA restriction site mapping
|
US7579160B2
(en)
*
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US20050026248A1
(en)
*
|
1998-03-26 |
2005-02-03 |
Hsueh Aaron J.W. |
Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions
|
DE19813774A1
(de)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
|
US6573095B1
(en)
*
|
1998-04-29 |
2003-06-03 |
Genesis Research & Development Corporation Limited |
Polynucleotides isolated from skin cells
|
WO1999058668A1
(fr)
*
|
1998-05-14 |
1999-11-18 |
Ono Pharmaceutical Co., Ltd. |
Nouveaux polypeptides, adn complementaires les codant et utilisation de ces polypeptides
|
US20030134327A1
(en)
*
|
1998-05-15 |
2003-07-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
WO1999061617A1
(en)
*
|
1998-05-29 |
1999-12-02 |
Human Genome Sciences, Inc. |
Interleukins-21 and 22
|
AU4411499A
(en)
*
|
1998-06-05 |
1999-12-20 |
Human Genome Sciences, Inc. |
Connective tissue growth factor-4
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
US7067473B1
(en)
*
|
1998-07-14 |
2006-06-27 |
Janssen Pharmaceutica N.V. |
Neurotrophic growth factor
|
HU226073B1
(en)
*
|
1998-07-14 |
2008-04-28 |
Janssen Pharmaceutica Nv |
Neurotrophic growth factor
|
US20070014787A1
(en)
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
US20050048612A1
(en)
*
|
1998-07-28 |
2005-03-03 |
Incyte Corporation |
Human epidermal proteins HEP1-1 to HEP1-6
|
US6706951B1
(en)
*
|
1998-08-17 |
2004-03-16 |
Pioneer Hi-Bred International, Inc. |
Maize nucleic acid encoding a GDP-mannose pyrophosphorylase
|
WO2000011199A1
(en)
*
|
1998-08-20 |
2000-03-02 |
Pioneer Hi-Bred International, Inc. |
COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
AU5801099A
(en)
*
|
1998-09-02 |
2000-03-21 |
Millennium Pharmaceuticals, Inc. |
14926 receptor, a novel g-protein coupled receptor
|
EP1417971A3
(de)
*
|
1998-09-09 |
2004-06-30 |
Scios Inc. |
Verwendung eines angiogenen Faktors zur Behandlung von mikrovaskulären Angiopathien
|
WO2000013702A2
(en)
*
|
1998-09-09 |
2000-03-16 |
Scios Inc. |
Use of an angiogenic factor for the treatment of microvascular angiopathies
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
JP2002525054A
(ja)
*
|
1998-09-17 |
2002-08-13 |
インサイト・ファーマスーティカルズ・インコーポレイテッド |
ヒトgpcrタンパク質
|
US6680380B1
(en)
*
|
1998-09-18 |
2004-01-20 |
Schering Corporation |
Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
|
US20040058355A1
(en)
*
|
1998-09-30 |
2004-03-25 |
Millennium Pharmaceuticals, Inc. |
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
|
WO2000018923A2
(en)
*
|
1998-09-30 |
2000-04-06 |
Millennium Pharmaceuticals, Inc. |
Slgp protein and nucleic acid molecule and uses therefor
|
WO2000021548A2
(en)
*
|
1998-10-13 |
2000-04-20 |
Chiron Corporation |
Angiogenically effective unit dose of fgf and method of administering
|
US20030166550A1
(en)
|
1999-08-27 |
2003-09-04 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US6440934B1
(en)
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20020072489A1
(en)
*
|
1998-10-13 |
2002-06-13 |
Whitehouse Martha J. |
Angiogenically effective unit dose of FGF-2 and method of use
|
US6375680B1
(en)
|
1998-12-01 |
2002-04-23 |
St. Jude Medical, Inc. |
Substrates for forming synthetic tissues
|
JP2002532083A
(ja)
*
|
1998-12-17 |
2002-10-02 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
47個のヒト分泌タンパク質
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
JP2000189171A
(ja)
*
|
1998-12-25 |
2000-07-11 |
Banyu Pharmaceut Co Ltd |
新規なグアノシン三リン酸(gtp)結合タンパク質共役型のレセプタ―タンパク質
|
US20030187196A1
(en)
*
|
1998-12-30 |
2003-10-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2000043520A2
(en)
*
|
1999-01-25 |
2000-07-27 |
University Of Florida |
Materials and methods for producing geminivirus resistant plants
|
WO2000046391A2
(en)
*
|
1999-02-02 |
2000-08-10 |
The Trustees Of Columbia University In The City Of New York |
Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
EP1159284A4
(de)
*
|
1999-02-10 |
2003-10-29 |
Human Genome Sciences Inc |
33 human sekrteierte proteine
|
DE19906096A1
(de)
*
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6392126B1
(en)
*
|
1999-02-25 |
2002-05-21 |
Pioneer Hi-Bred International, Inc. |
Adenosine deaminase homologues and uses thereof
|
US6406907B1
(en)
*
|
1999-02-26 |
2002-06-18 |
Iowa State University Research Foundation |
Bovine tumor necrosis factor receptor-1 and methods of use
|
US7083793B2
(en)
*
|
1999-02-26 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Tango 243 polypeptides and uses thereof
|
EP1157118A4
(de)
*
|
1999-03-01 |
2002-07-17 |
Insight Strategy & Marketing |
POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
|
IL128852A0
(en)
*
|
1999-03-05 |
2000-01-31 |
Compugen Ltd |
Novel nucleic acid and amino acid sequences
|
US6783954B2
(en)
*
|
1999-03-05 |
2004-08-31 |
Compugen Ltd. |
VEGF nucleic acid and amino acid sequences
|
US6689866B1
(en)
*
|
1999-03-09 |
2004-02-10 |
Curagen Corporation |
Polynucleotides and proteins encoded thereby
|
US8410248B2
(en)
*
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US8133734B2
(en)
*
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
US6965012B1
(en)
*
|
1999-03-30 |
2005-11-15 |
Eli Lilly And Company |
Flint polypeptide analogs
|
AU779402B2
(en)
*
|
1999-04-12 |
2005-01-20 |
Genentech Inc. |
Tumor necrosis factor homologs and nucleic acids encoding the same
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
WO2000064261A1
(en)
*
|
1999-04-26 |
2000-11-02 |
Ludwig Institute For Cancer Research |
Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
|
WO2000064946A2
(en)
|
1999-04-28 |
2000-11-02 |
Board Of Regents, The University Of Texas System |
Compositions and methods for cancer treatment by selectively inhibiting vegf
|
EP1179590A4
(de)
*
|
1999-04-30 |
2002-09-18 |
Kurokawa Kiyoshi |
Protein meg-3
|
US6475987B1
(en)
*
|
1999-05-06 |
2002-11-05 |
National Jewish Medical And Research Center |
Tall-1 receptor homologues
|
JP2003500053A
(ja)
*
|
1999-05-20 |
2003-01-07 |
サイオス,インコーポレーテッド |
血管内皮増殖因子ダイマー
|
US6475796B1
(en)
*
|
1999-05-20 |
2002-11-05 |
Scios, Inc. |
Vascular endothelial growth factor variants
|
KR20030000011A
(ko)
*
|
1999-05-25 |
2003-01-03 |
휴먼 게놈 사이언시즈, 인크. |
Meth-1 및 meth-2 폴리뉴클레오티드 및폴리펩티드
|
US20030207793A1
(en)
*
|
1999-05-26 |
2003-11-06 |
Conklin Darrell C. |
Secreted alpha-helical protein - 32
|
US6781028B1
(en)
*
|
1999-06-14 |
2004-08-24 |
Exelixis, Inc. |
Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
|
US20030153050A1
(en)
*
|
1999-06-28 |
2003-08-14 |
Conklin Darrell C. |
Helical polypeptide zalpha29
|
US20030096355A1
(en)
*
|
1999-07-09 |
2003-05-22 |
Ke Zhang |
Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
|
US6951738B2
(en)
*
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
ATE366813T1
(de)
|
1999-07-23 |
2007-08-15 |
Kenji Kangawa |
Neue peptide
|
WO2001010891A2
(en)
*
|
1999-08-05 |
2001-02-15 |
Research Corporation Technologies, Inc. |
Il-16 antagonists
|
US20030134788A1
(en)
*
|
1999-08-12 |
2003-07-17 |
Baker Kevin P. |
Human tumor necrosis factor receptor TR16
|
US20040214783A1
(en)
*
|
2002-05-08 |
2004-10-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
NZ523206A
(en)
*
|
1999-08-31 |
2004-12-24 |
Genentech Inc |
Antibodies that bind to tumor gene sequences
|
US20030120037A1
(en)
*
|
1999-09-22 |
2003-06-26 |
Ji Ming Wang |
Utilization of FPRL1 as a functional receptor by serum amyloid a (SAA)
|
USRE39849E1
(en)
|
1999-10-12 |
2007-09-18 |
Chemocentryx, Inc. |
Methods for identifying modulators of CCX CKR activity
|
US6998239B1
(en)
*
|
1999-10-12 |
2006-02-14 |
Chemocentryx, Inc. |
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
|
AU784052B2
(en)
*
|
1999-10-18 |
2006-01-19 |
Lexicon Genetics Incorporated |
Novel human proteins and polynucleotides encoding the same
|
US7459308B2
(en)
*
|
1999-10-21 |
2008-12-02 |
Arbor Vita Corporation |
Nucleic acid molecule encoding a CLASP-2 transmembrane protein
|
US6726718B1
(en)
|
1999-12-13 |
2004-04-27 |
St. Jude Medical, Inc. |
Medical articles prepared for cell adhesion
|
US7029857B1
(en)
*
|
1999-12-17 |
2006-04-18 |
H. Lundbeck A/S |
Processes for obtaining compounds employing SNORF72 receptors
|
JP2001211886A
(ja)
*
|
2000-02-07 |
2001-08-07 |
Japan Science & Technology Corp |
L−体及びd−体アミノ酸を輸送するナトリウム非依存性小型中性アミノ酸トランスポーター及びその遺伝子
|
AU3495301A
(en)
*
|
2000-02-11 |
2001-08-20 |
Biogen Inc |
Heterologous polypeptide of the tnf family
|
US6965010B2
(en)
*
|
2000-02-25 |
2005-11-15 |
Licentia, Ltd. |
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
|
US20030165891A1
(en)
*
|
2000-02-29 |
2003-09-04 |
Millennium Pharmaceuticals, Inc. |
Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9 alpha2delta-4, 54414, and 53763 molecules and uses therefor
|
WO2001065927A1
(en)
*
|
2000-03-03 |
2001-09-13 |
University Of Utah Research Foundation |
Mass1 gene, a target for anticonvulsant drug development
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US20030119739A1
(en)
*
|
2000-03-29 |
2003-06-26 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
|
US7070946B2
(en)
*
|
2000-05-23 |
2006-07-04 |
Tanabe Seiyaku Co., Ltd. |
Bone metabolism related protein and gene thereof
|
MXPA02011938A
(es)
*
|
2000-05-31 |
2004-09-06 |
Johnson & Johnson |
Adn que codifica para un receptor de histamina de mamifero del subtipo h4.
|
US20030059461A1
(en)
*
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
US7355019B2
(en)
*
|
2000-06-06 |
2008-04-08 |
Sibtech, Inc. |
Cysteine-containing peptide tag for site-specific conjugation of proteins
|
US20040038235A1
(en)
*
|
2000-06-21 |
2004-02-26 |
Kluxen Franz Werner |
A g-protein coupled receptor
|
AU8473401A
(en)
*
|
2000-08-04 |
2002-02-18 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
AU2001283229A1
(en)
*
|
2000-08-07 |
2002-02-18 |
Zymogenetics Inc. |
Snake venom polypeptide zsnk1
|
US7153669B2
(en)
*
|
2000-09-05 |
2006-12-26 |
Amgen Inc. |
Nucleic acids encoding MK61 receptors
|
EP1356045A2
(de)
*
|
2000-10-13 |
2003-10-29 |
Nuvelo, Inc. |
Egf motiv protein, egfl6 materialien und methoden
|
US6489456B1
(en)
*
|
2000-10-27 |
2002-12-03 |
Pe Corporation (Ny) |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
GB0028971D0
(en)
*
|
2000-11-28 |
2001-01-10 |
Inpharmatica Ltd |
Novel proteins
|
AU2002228841C1
(en)
*
|
2000-12-07 |
2006-11-23 |
Sangamo Biosciences, Inc |
Regulation of angiogenesis with zinc finger proteins
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
US20040072997A1
(en)
*
|
2000-12-20 |
2004-04-15 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
WO2002077155A2
(en)
*
|
2001-01-08 |
2002-10-03 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US20030180309A1
(en)
*
|
2001-01-08 |
2003-09-25 |
Baum Peter R. |
Human B7 polypeptides
|
US7442370B2
(en)
*
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
AU2002258394A1
(en)
*
|
2001-02-07 |
2002-09-12 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
WO2002067978A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Wyeth |
Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
US7741049B2
(en)
*
|
2001-03-15 |
2010-06-22 |
Sumitomo Chemical Company, Limited |
Analysis of agonist-activity and antagonist-activity to cytokinin receptor
|
US6962971B2
(en)
*
|
2001-03-16 |
2005-11-08 |
The Regents Of The University Of California |
Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
|
AU2002257703A1
(en)
*
|
2001-03-23 |
2002-10-08 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders
|
ATE512216T1
(de)
*
|
2001-04-10 |
2011-06-15 |
Agensys Inc |
Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
|
US20030027751A1
(en)
*
|
2001-04-10 |
2003-02-06 |
Genvec, Inc. |
VEGF fusion proteins
|
US7795218B2
(en)
*
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
DK1385864T3
(da)
|
2001-04-13 |
2010-08-16 |
Human Genome Sciences Inc |
Anti-VEGF-2-antistoffer
|
US20030170786A1
(en)
*
|
2001-04-13 |
2003-09-11 |
Rosen Craig A. |
Vascular endothelial growth factor 2
|
US20050232921A1
(en)
*
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
AU2002252631A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
US6660737B2
(en)
|
2001-05-04 |
2003-12-09 |
The Procter & Gamble Company |
Medicinal uses of hydrazones
|
US6878729B2
(en)
|
2001-05-04 |
2005-04-12 |
The Procter & Gamble Company |
Medicinal uses of dihydropyrazoles
|
GB0119015D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Cardiff |
A fusion protein
|
WO2003102029A1
(en)
*
|
2001-08-15 |
2003-12-11 |
Endocube Sas |
Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
|
CA2457781A1
(en)
*
|
2001-08-21 |
2003-02-27 |
Chiron Corporation |
Kgf polypeptide compositions
|
AU2002331669A1
(en)
*
|
2001-08-23 |
2003-03-10 |
The Wistar Institute Of Anatomy And Biology |
An organotypic intestinal culture and methods of use thereof
|
MXPA04001986A
(es)
*
|
2001-08-29 |
2004-06-07 |
Genentech Inc |
Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
|
US20050222070A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
US20040214766A1
(en)
*
|
2001-10-01 |
2004-10-28 |
Kari Alitalo |
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
WO2003033727A1
(fr)
*
|
2001-10-12 |
2003-04-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Procede de criblage d'un inhibiteur de la mort cellulaire
|
EP1578907A2
(de)
*
|
2001-10-17 |
2005-09-28 |
ZymoGenetics, Inc. |
Sezerniertes protein, ztnf9
|
US7371258B2
(en)
*
|
2001-10-26 |
2008-05-13 |
St. Jude Medical, Inc. |
Valved prosthesis with porous substrate
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US20030093147A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Ogle Matthew F. |
Medical devices that stimulate growth factor production
|
US20050137130A1
(en)
*
|
2001-11-14 |
2005-06-23 |
Bodmer Mark W. |
Medical treatment
|
AU2002351175A1
(en)
*
|
2001-11-26 |
2003-06-10 |
Bristol-Myers Squibb Company |
Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
|
US20030104496A1
(en)
*
|
2001-11-30 |
2003-06-05 |
Cytokinetics, Inc. |
Novel motor protein of P. falciparum and methods for its use
|
US7795213B2
(en)
*
|
2001-12-13 |
2010-09-14 |
Posco |
Methods of contacting β amyloid protein with VEGF
|
US20030171556A1
(en)
*
|
2001-12-13 |
2003-09-11 |
Chi-Bom Chae |
Beta-amyloid binding factors and inhibitors thereof
|
CA2472927A1
(en)
*
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
US20040162237A1
(en)
*
|
2002-01-15 |
2004-08-19 |
Fox Niles Wayne |
Use of lp82 to treat body weight disorders
|
KR20030062788A
(ko)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 mph1-btm 및 이것을포함하는 생명공학제품
|
KR20030062789A
(ko)
*
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 sim2-btm 및 이것을포함하는 생명공학제품
|
WO2003066808A2
(en)
*
|
2002-01-23 |
2003-08-14 |
Texas Tech University |
Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
|
AU2003215548A1
(en)
*
|
2002-02-01 |
2003-09-02 |
Bayer Healthcare Ag |
Regulation of human hematopoietin receptor-like protein
|
GB0202906D0
(en)
*
|
2002-02-07 |
2002-03-27 |
Univ London |
Prevention of myocardial damage
|
AU2003214171A1
(en)
*
|
2002-03-12 |
2003-09-29 |
Harold Brem |
Method for treating diabetic ulcers
|
US20060263770A1
(en)
*
|
2002-03-22 |
2006-11-23 |
Marco Colonna |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
ES2286450T3
(es)
*
|
2002-03-28 |
2007-12-01 |
The Genetics Company Inc. |
Proteinas de regulacion del crecimiento.
|
CA2482387C
(en)
*
|
2002-04-18 |
2015-03-03 |
Yeda Research And Development Co. Ltd |
Derivatives of the nf-kappab inducing enzyme, their preparation and use
|
EP1505074A4
(de)
*
|
2002-04-24 |
2005-12-21 |
Banyu Pharma Co Ltd |
Konstitutiv aktive mutanten eines histamin h3 rezeptors und deren verwendungen
|
US20030055221A1
(en)
*
|
2002-05-07 |
2003-03-20 |
Jirong Lu |
Stability of flint through o-linked glycosylation
|
EP1382613A1
(de)
*
|
2002-07-16 |
2004-01-21 |
Sumitomo Chemical Company, Limited |
Neues G Protein, kodierende Nukleotidsequenzen und Verwendung des Proteins
|
US7335362B2
(en)
*
|
2002-07-19 |
2008-02-26 |
Beth Israel Deaconess Medical Center |
Methods of treating pre-eclampsia or eclampsia
|
AP2005003230A0
(en)
*
|
2002-07-19 |
2005-03-31 |
Beth Israel Hospital |
Methods of diagnosing and treating pre-eclampsia or eclampsia.
|
US7435419B2
(en)
*
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
GB0219303D0
(en)
*
|
2002-08-19 |
2002-09-25 |
Ares Trading Sa |
Protein
|
AU2003267563A1
(en)
*
|
2002-09-10 |
2004-04-30 |
Lorantis Limited |
Pharmaceutical composition and medical treatments comprising notch ligand proteins
|
JP4563813B2
(ja)
*
|
2002-10-08 |
2010-10-13 |
アレス トレーディング ソシエテ アノニム |
Il−18bpに結合でき、第2サイトカインの活性を阻害するサイトカインの使用
|
GB0223984D0
(en)
*
|
2002-10-15 |
2002-11-20 |
Novartis Forschungsstiftung |
Methods for detecting teneurin signalling and related screening methods
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
US20040120950A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Kari Alitalo |
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
|
US20040235747A1
(en)
*
|
2003-01-02 |
2004-11-25 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating and/or preventing autoimmune diseases
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
EP1590462A2
(de)
*
|
2003-02-05 |
2005-11-02 |
Applied Research Systems ARS Holding N.V. |
Mucinähnliche polypeptide
|
EP1613348B1
(de)
*
|
2003-03-12 |
2010-06-23 |
The Arizona Board of Regents on Behalf of the University of Arizona |
Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
|
US7084246B2
(en)
*
|
2003-04-17 |
2006-08-01 |
Molecular Logix, Inc. |
Epidermal growth factor agonists
|
JP4742030B2
(ja)
|
2003-04-18 |
2011-08-10 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
ポリマーが結合したグリコシル化ニューブラスチン
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
WO2005110009A2
(en)
*
|
2003-07-22 |
2005-11-24 |
Immunex Corporation |
COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
PL1660057T3
(pl)
*
|
2003-08-27 |
2012-10-31 |
Ophthotech Corp |
Terapia łączona do leczenia zaburzeń związanych z neowaskularyzacją gałki ocznej
|
WO2005023288A1
(en)
*
|
2003-09-08 |
2005-03-17 |
Applied Research Systems Ars Holding N.V. |
Treatment of fibrotic disease
|
EP1672062B1
(de)
*
|
2003-09-11 |
2012-05-09 |
Hubit Genomix, Inc. |
Verfahren und kit zum nachweis von sklerose verursachenden proliferativen erkrankungen und/oder heilmittel gegen sklerose verursachende proliferative erkrankungen sowie verfahren und kit zur identifizierung einer bei der vorbeugung und/oder behandlung von sklerose verursachenden proliferativen erkrankungen wirksamen substanz
|
ZA200603396B
(en)
*
|
2003-09-29 |
2007-11-28 |
Warren Pharmaceuticals Inc |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
WO2005040194A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Ludwig Institute For Cancer Research |
Methods and compositions for pdgf-c activation and inhibition
|
CA2545603A1
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
Neonatal fc receptor (fcrn)-binding polypeptide variants, dimeric fc binding proteins and methods related thereto
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
CA2548769A1
(en)
*
|
2003-12-16 |
2005-06-30 |
Zymogenetics, Inc. |
Ztnf 12, a tumor necrosis factor
|
JP2008502317A
(ja)
*
|
2003-12-30 |
2008-01-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
Il−7融合タンパク質
|
US20050176073A1
(en)
*
|
2004-02-06 |
2005-08-11 |
Chemocentryx, Inc. |
Cell proliferation associated with CCX CKR expression
|
EP1773349A4
(de)
*
|
2004-05-04 |
2009-07-29 |
Childrens Medical Center |
Verfahren und zusammensetzungen zur behandlung von präeklampsie
|
ATE389960T1
(de)
*
|
2004-06-30 |
2008-04-15 |
Tyco Electronics Nederland Bv |
Verbinder für elektronische bauteile
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008513356A
(ja)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
SE0402025D0
(sv)
*
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
JP2008509928A
(ja)
*
|
2004-08-13 |
2008-04-03 |
アノーメド インコーポレイテッド |
前駆/幹細胞を動員するためのケモカインの組み合わせ
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
AU2005277227B2
(en)
*
|
2004-08-19 |
2011-10-06 |
Biogen Ma Inc. |
Refolding transforming growth factor beta family proteins
|
EP2335713A3
(de)
*
|
2004-08-19 |
2011-11-02 |
Biogen Idec MA Inc. |
Neublastinvarianten
|
US20070166281A1
(en)
*
|
2004-08-21 |
2007-07-19 |
Kosak Kenneth M |
Chloroquine coupled antibodies and other proteins with methods for their synthesis
|
US20080171033A1
(en)
*
|
2004-08-26 |
2008-07-17 |
Chiwen Chang |
Compositions and methods for treating diseases associated with angiogenesis and inflammation
|
BRPI0515884A
(pt)
|
2004-09-24 |
2008-08-12 |
Beth Israel Hospital |
métodos de diagnóstico e tratamento de complicações da gravidez
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
US20060090646A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Questair Technologies Inc. |
Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons
|
EP2377555A3
(de)
|
2004-11-18 |
2011-11-23 |
Imclone LLC |
Antikörper gegen den vaskulären endothelialen Wachstumsfaktorrezeptor-1
|
US20080026410A1
(en)
*
|
2004-12-02 |
2008-01-31 |
Antonia Vlahou |
Biomarkers for Bladder Cancer
|
CN101299962A
(zh)
*
|
2004-12-15 |
2008-11-05 |
貝丝以色列女执事医疗中心 |
可用于诊断和治疗妊娠并发症的核酸和多肽
|
KR20070100346A
(ko)
|
2005-01-05 |
2007-10-10 |
바이오겐 아이덱 엠에이 인코포레이티드 |
크립토 결합 분자
|
WO2006094106A2
(en)
|
2005-02-28 |
2006-09-08 |
Sangamo Biosciences, Inc. |
Anti-angiogenic methods and compositions
|
WO2006097682A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Ucl Business Plc |
Mechano growth factor peptides and their use
|
JP2008537777A
(ja)
*
|
2005-03-23 |
2008-09-25 |
ワイス |
Gdf−8調節剤に対する免疫応答の検出
|
US7767789B2
(en)
*
|
2005-06-02 |
2010-08-03 |
University Hopitals of Cleveland |
Truncated proteins as cancer markers
|
JP2008547006A
(ja)
*
|
2005-06-17 |
2008-12-25 |
ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド |
変形性関節症のタンパク質プロフィール
|
AU2006259408A1
(en)
*
|
2005-06-17 |
2006-12-28 |
Genentech, Inc. |
Use of VEGF for wound healing
|
WO2007024752A2
(en)
*
|
2005-08-26 |
2007-03-01 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
|
CA2633554C
(en)
|
2005-12-22 |
2012-11-13 |
Genetech, Inc. |
Recombinant production of heparin binding proteins
|
US7659250B2
(en)
*
|
2005-12-22 |
2010-02-09 |
Centocor, Inc. |
BMP-7 variant compositions, methods and uses
|
US20080064631A1
(en)
*
|
2006-01-13 |
2008-03-13 |
Jeffrey Molldrem |
T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
|
TWI501774B
(zh)
*
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP1993590B1
(de)
*
|
2006-03-01 |
2013-12-25 |
Biogen Idec MA Inc. |
Zusammensetzungen und verfahren zur verabreichung von proteinen der gdnf-liganden-familie
|
US9878003B2
(en)
|
2006-03-06 |
2018-01-30 |
The University Of Manchester |
Method of treating bone disorders using TSG-6
|
GB0604460D0
(en)
*
|
2006-03-06 |
2006-04-12 |
Isis Innovation |
Treatment
|
WO2007130619A1
(en)
*
|
2006-05-03 |
2007-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulating osteoclast differentiation, activation and bone resorption
|
EP2548578B1
(de)
|
2006-05-17 |
2014-08-20 |
The Ludwig Institute for Cancer Research |
Targeting der Regulierung von Fettsäuretransportern durch VEGF-B zur Modulation menschlicher Krankheiten
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
EP2046394B1
(de)
*
|
2006-07-04 |
2014-12-17 |
Combigene AB |
Verwendung von nukleinsäuresequenzen zur behandlung von neurologischen und psychiatrischen erkrankungen, vektoren und zusammensetzungen
|
KR101520105B1
(ko)
|
2006-07-14 |
2015-05-21 |
제넨테크, 인크. |
재조합 단백질의 리폴딩
|
CN101500595A
(zh)
*
|
2006-08-07 |
2009-08-05 |
健赞股份有限公司 |
组合治疗
|
US8865169B2
(en)
*
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
US9023352B2
(en)
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
KR100984483B1
(ko)
*
|
2007-03-19 |
2010-10-01 |
(주)바이오니아 |
순환적 역전사 방법
|
WO2008116111A2
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
|
US8673859B2
(en)
*
|
2007-03-20 |
2014-03-18 |
New York University |
GM-CSF cosmeceutical compositions and methods of use thereof
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
ES2476253T3
(es)
|
2007-05-01 |
2014-07-14 |
Biogen Idec Ma Inc. |
P�ptidos de neublastina para su uso en el aumento de la vascularizaci�n en tejido con flujo sanguíneo deteriorado
|
WO2009020964A2
(en)
*
|
2007-08-08 |
2009-02-12 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
EP2271365A4
(de)
*
|
2008-04-09 |
2011-10-26 |
Ludwig Inst Cancer Res |
Regulierung von fettsäuretransportern
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
US20120190042A1
(en)
*
|
2009-01-22 |
2012-07-26 |
Reuben Gobezie |
Protein biomarkers and therapeutic targets for osteoarthritis
|
EP3058986B1
(de)
|
2009-03-30 |
2018-05-09 |
Acceleron Pharma Inc. |
Bmp-alk3-antagonisten und ihre verwendung zur förderung des knochenwachstums
|
US20100279882A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Mostafa Ronaghi |
Sequencing methods
|
MX371080B
(es)
*
|
2009-06-23 |
2020-01-15 |
Univ California |
Aumento de retención de bmp.
|
US9409983B2
(en)
*
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011103389A1
(en)
*
|
2010-02-19 |
2011-08-25 |
Cornell University |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
WO2011105648A1
(ko)
*
|
2010-02-26 |
2011-09-01 |
오스템임플란트 주식회사 |
조골세포 분화능을 증진시키는 올리고펩타이드
|
US20110218141A1
(en)
*
|
2010-03-03 |
2011-09-08 |
Hamrick Mark W |
Leptin therapy to increase muscle mass and to treat muscle wasting conditions
|
AU2011252954B2
(en)
|
2010-05-14 |
2015-04-16 |
Beth Israel Deaconess Medical Center |
Extracorporeal devices and methods of treating complications of pregnancy
|
WO2011160062A2
(en)
*
|
2010-06-17 |
2011-12-22 |
The Usa As Represented By The Secretary, National Institutes Of Health |
Compositions and methods for treating inflammatory conditions
|
MX2013000301A
(es)
|
2010-07-09 |
2013-05-09 |
Biogen Idec Hemophilia Inc |
Factores quimericos de coagulacion.
|
US20120171769A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Mcgonigle Joseph S |
Cell attachment coatings and methods
|
US9738707B2
(en)
|
2011-07-15 |
2017-08-22 |
Biogen Ma Inc. |
Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
|
US8507446B2
(en)
*
|
2011-08-09 |
2013-08-13 |
Mackay Memorial Hospital |
Use of PEDF-derived polypeptides for treating liver cirrhosis
|
WO2013106577A2
(en)
|
2012-01-10 |
2013-07-18 |
Biogen Idec Ma Inc. |
Enhancement of transport of therapeutic molecules across the blood brain barrier
|
US9920295B2
(en)
*
|
2012-02-21 |
2018-03-20 |
The Trustees Of The University Of Pennsylvania |
Bioreactor for isolation of rare cells and methods of use
|
CA2862516C
(en)
|
2012-03-27 |
2023-02-14 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
US9133440B2
(en)
*
|
2012-09-27 |
2015-09-15 |
Claresa Levetan |
Generation of new pancreatic beta cells
|
RU2704285C2
(ru)
|
2013-01-30 |
2019-10-25 |
Нгм Байофармасьютикалз, Инк. |
Композиции и способы применения для лечения метаболических расстройств
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
AU2014228938B2
(en)
|
2013-03-15 |
2019-05-02 |
Bioverativ Therapeutics Inc. |
Factor IX polypeptide formulations
|
JP2016531901A
(ja)
|
2013-07-12 |
2016-10-13 |
オプソテック コーポレイションOphthotech Corporation |
眼科症状を処置するまたは予防するための方法
|
WO2015100360A1
(en)
*
|
2013-12-23 |
2015-07-02 |
Alk-Abelló A/S |
Peptide combinations and uses thereof in treating dust mite allergy
|
EP3174894B1
(de)
*
|
2014-07-30 |
2021-06-23 |
NGM Biopharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
|
MY186702A
(en)
|
2014-10-31 |
2021-08-11 |
Ngm Biopharmaceuticals Inc |
Compositions and methods of use for treating metabolic disorders
|
US11001625B2
(en)
|
2014-12-10 |
2021-05-11 |
Tufts University |
VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor
|
EP3954993A1
(de)
|
2015-02-04 |
2022-02-16 |
Bristol-Myers Squibb Company |
Verfahren zur auswahl therapeutischer moleküle
|
DK3253875T3
(da)
|
2015-02-04 |
2020-04-14 |
H Hoffmann La Roche Ag |
Tau-antisense-oligomerer og anvendelser deraf
|
HUE057431T2
(hu)
|
2015-04-03 |
2022-05-28 |
Univ Massachusetts |
Oligonukleotid vegyületek preeklampszia és más angiogén rendellenességek kezelésére
|
WO2017030973A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
EP3408391A4
(de)
|
2016-01-31 |
2019-08-28 |
University of Massachusetts |
Verzweigte oligonukleotide
|
CA3016035A1
(en)
|
2016-03-31 |
2017-10-05 |
Ngm Biopharmaceuticals, Inc. |
Binding proteins and methods of use thereof
|
CA3033368A1
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
US10844377B2
(en)
|
2017-06-23 |
2020-11-24 |
University Of Massachusetts |
Two-tailed self-delivering siRNA
|
EP3833763A4
(de)
|
2018-08-10 |
2023-07-19 |
University of Massachusetts |
Modifizierte oligonukleotide zum targeting von snps
|
BR112022002307A2
(pt)
|
2019-08-09 |
2022-06-28 |
Univ Massachusetts |
Oligonucleotídeos quimicamente modificados que têm como alvo snps
|
US12077576B2
(en)
|
2020-07-02 |
2024-09-03 |
Trustees Of Tufts College |
VHH polypeptides that bind to Clostridium difficile toxin b and methods of use thereof
|
KR20240040729A
(ko)
|
2021-06-23 |
2024-03-28 |
유니버시티 오브 매사추세츠 |
자간전증 및 기타 혈관신생 질환의 치료를 위한 최적화된 항-flt1 올리고뉴클레오타이드 화합물
|